Health Care [ 3/12 ] | Life Sciences Tools & Services [ 29/74 ]
NYSE | Common Stock
Revvity, Inc. provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally.
The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services.
Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.
Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions.
This segment also develops technologies that enable and support genomic workflows using protein coupled receptor and next-generation DNA sequencing for applications in oncology, immunodiagnostics, and drug discovery.
It serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies under the AutoDELFIA, BACS-on-Beads, BIOCHIPs, Bioo Scientific,BoBs , chemagic, Chitas, DELFIA, DELFIA Xpress, DOPlify, EONIS, EUROArray, EUROIMMUN, EUROLabWorkstation, EUROLINE, EUROPattern, Evolution Evoya, explorer, Fontus, Genoglyphix, GSP, Haoyuan, IDS, IDS-i10 IDS-i10T, IDS-iSYS, iLab, iQ, JANUS, LabChip, LifeCycle, LimsLink, Migele, MultiPROBE, NEXTFLEX, NextPrep, Pannoramic, Panthera Puncher, PG-Seq, PGFind PKamp, PreNAT II, Prime, Protein Clear, ProteinEXact, QSigh, QuantiVac, RONIA, Sciclone, SimplicityChrom, Specimen Gate,Superflex, Symbio, T-SPOT, Touch, Twister, Vanadis, VariSpec, ViaCord VICTOR 2D, and Zephyr brand name.
The company was formerly known as PerkinElmer, Inc. and changed its name to Revvity, Inc. in April 2023.
Revvity, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Oct 28, 24 | 1.28 Increased by +8.47% | 1.13 Increased by +13.27% |
| Jul 29, 24 | 1.22 Increased by +0.83% | 1.12 Increased by +8.93% |
| Apr 29, 24 | 0.98 Decreased by -2.97% | 0.93 Increased by +5.38% |
| Feb 1, 24 | 1.25 Decreased by -26.47% | 1.16 Increased by +7.76% |
| Oct 30, 23 | 1.18 Decreased by -21.85% | 1.19 Decreased by -0.84% |
| Aug 1, 23 | 1.21 Decreased by -47.84% | 1.19 Increased by +1.68% |
| May 11, 23 | 1.01 Decreased by -58.09% | 1.06 Decreased by -4.72% |
| Feb 14, 23 | 1.70 Decreased by -33.59% | 1.64 Increased by +3.66% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Sep 30, 24 | 684.05 M Increased by +1.98% | 93.39 M Increased by +883.32% | Increased by +13.65% Increased by +864.19% |
| Jun 30, 24 | 691.68 M Decreased by -2.45% | 79.11 M Increased by +122.47% | Increased by +11.44% Increased by +128.06% |
| Mar 31, 24 | 649.92 M Decreased by -3.70% | 26.01 M Increased by +4.70% | Increased by +4.00% Increased by +8.72% |
| Dec 31, 23 | 695.90 M Decreased by -6.11% | 78.56 M Decreased by -38.46% | Increased by +11.29% Decreased by -34.45% |
| Sep 30, 23 | 670.74 M Decreased by -5.77% | 9.50 M Decreased by -88.87% | Increased by +1.42% Decreased by -88.19% |
| Jun 30, 23 | 709.07 M Decreased by -42.33% | 35.56 M Decreased by -80.16% | Increased by +5.01% Decreased by -65.59% |
| Mar 31, 23 | 674.87 M Decreased by -46.42% | 24.84 M Decreased by -85.96% | Increased by +3.68% Decreased by -73.80% |
| Dec 31, 22 | 741.21 M Decreased by -45.67% | 127.66 M Decreased by -32.88% | Increased by +17.22% Increased by +23.55% |